eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2021
vol. 38
 
Share:
Share:
abstract:
Review paper

Controversy around the morphea

Aleksandra Dańczak-Pazdrowska
1
,
Paulina Cieplewicz
1
,
Ryszard Żaba
2
,
Zygmunt Adamski
1
,
Adriana Polańska
2

1.
Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland
2.
Department of Dermatology and Venereology, Poznan University of Medical Sciences, Poznan, Poland
Adv Dermatol Allergol 2021; XXXVIII (5): 716-720
Online publish date: 2021/05/18
View full text Get citation
 
Morphea, also known as localized scleroderma, is a chronic, autoimmune disease of connective tissue. It is characterized by a typical clinical feature. In morphea, there is no Raynaud’s phenomenon, no sclerodactyly or no ulcerations on the fingertips. Although morphea and systemic sclerosis have been perceived as separate disease entities for years, they are still confused both by patients (which is a source of unnecessary stress) and doctors. This may be due to, in part, misunderstood terminology. The controversy around morphea also concerns the division of this disease entity, including its less common subtypes, such as eosinophilic fasciitis. Discussions also revolve around the diagnostic aspects and possible treatment options. The paper attempts to present the debatable aspects regarding nomenclature, classification, diagnosis and treatment of morphea.
keywords:

morphea, localized scleroderma, eosinophilic fasciitis, penicillin

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.